Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure

Circulation Journal

Volumn 72, Issue 3, 2008, Pages 364-369

  Shinagawa, Hisahito ^a   Inomata, Takayuki ^a   Koitabashi, Toshimi ^a   Nakano, Hironari ^a   Takeuchi, Ichiro ^a   Naruke, Takashi ^a   Ohsaka, Tsutomu ^a   Nishii, Mototsugu ^a   Takehana, Hitoshi ^a   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute exacerbation; Bilirubin; Heart failure; Liver function test; Prognosis

Indexed keywords

BILIRUBIN;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CENTRAL VENOUS PRESSURE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE EXACERBATION; FEMALE; HAZARD RATIO; HEART DEATH; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HUMAN TISSUE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION; PREDICTION; PREDICTOR VARIABLE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE; TISSUE PERFUSION;

AGED; BILIRUBIN; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 42649114811     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.364     Document Type: Article

References (20)

1. Batin P, Wickens M, McEntegart D, Fullwood L, Cowley J. The importance of abnormality of liver function tests in predicting mortality in chronic heart failure. Eur Heart J 1995; 16: 1613-1618.
2. Sherlock S. The liver in heart failure: Relation of anatomical, functional, and circulatory changes. Br Heart J 1951; 13: 273-293.
3. Dunn GD, Hayes P, Breen KJ, Schenker S. The liver in congestive heart failure: A review. Am J Med Sci 1973; 265: 174-189.
4. Lau GT, Tan HC, Krimarides L. Type of dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 2002; 90: 1405-1409.
5. Naschitz JE, Slobodin G, Lewis RJ, Zuckermqn E, Yashurun D. Heart disease affecting the liver and liver diseases affecting the heart. Am Heart J 2000; 140: 111-120.
6. Ho KL, Prinsly JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 1993; 22(Suppl): 6A.
7. th edn. Oxford: Blackwell Science; 2002; 199-203.
8. th edn. Philadelphia: Willis C. Maddrey; 2003; 1328-1340.
9. Kubo SH, Walter BA, John DH, Clark M, Cody RJ. Liver function abnormalities in chronic heart failure: Influence of systemic hemodynamics. Arch Intern Med 1987; 147: 1227-1230.
10. Reese AJ. The effect of hypoxia on liver secretion studied by intravital fluorescence microscopy. Br J Exp Pathol 1960; 41: 527-535.
11. Shorey J, Schenker S, Combes B. Effect of acute hypoxia on hepatic excretory function. Am J Physiol 1969; 216: 1441-1452.
12. Kramer MR, Marshall SE, Tiroke A, Lewiston NJ, Starnes VA, Theodore J. Clinical significance of hyperbilirubinemia in patients with pulmonary hypertension undergoing heart-lung transplantation. J Heart Lung Transplant 1991; 10: 317-321.
13. th edn. New York: Elsevier; 2006; 235-237.
14. Richman SM, Delman AJ, Grob D. Alteration in indices of liver function in congestive heart failure with particular reference to serum enzymes. Am J Med 1961; 30: 211-225.
15. Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003; 41: 1797-1804.
16. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: Analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002; 106: 416-422.
17. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002; 105: 2392-2397.
18. Parsonage WA, Galbraith AJ, Koerbin GL, Potter JM. Value of B-type natriuretic peptide for identifying significantly elevated pulmonary artery wedge pressure in patients treated for established chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2005; 95: 883-885.
19. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135: 825-832.
20. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.